1. Home
  2. GETY vs AVXL Comparison

GETY vs AVXL Comparison

Compare GETY & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GETY
  • AVXL
  • Stock Information
  • Founded
  • GETY 1995
  • AVXL 2004
  • Country
  • GETY United States
  • AVXL United States
  • Employees
  • GETY N/A
  • AVXL N/A
  • Industry
  • GETY Industrial Machinery/Components
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GETY Industrials
  • AVXL Health Care
  • Exchange
  • GETY Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • GETY 723.5M
  • AVXL 794.0M
  • IPO Year
  • GETY N/A
  • AVXL N/A
  • Fundamental
  • Price
  • GETY $1.78
  • AVXL $10.60
  • Analyst Decision
  • GETY Hold
  • AVXL Strong Buy
  • Analyst Count
  • GETY 5
  • AVXL 2
  • Target Price
  • GETY $4.35
  • AVXL $44.00
  • AVG Volume (30 Days)
  • GETY 1.3M
  • AVXL 942.9K
  • Earning Date
  • GETY 08-08-2025
  • AVXL 08-05-2025
  • Dividend Yield
  • GETY N/A
  • AVXL N/A
  • EPS Growth
  • GETY N/A
  • AVXL N/A
  • EPS
  • GETY N/A
  • AVXL N/A
  • Revenue
  • GETY $941,086,000.00
  • AVXL N/A
  • Revenue This Year
  • GETY $2.71
  • AVXL N/A
  • Revenue Next Year
  • GETY $2.74
  • AVXL N/A
  • P/E Ratio
  • GETY N/A
  • AVXL N/A
  • Revenue Growth
  • GETY 4.20
  • AVXL N/A
  • 52 Week Low
  • GETY $1.25
  • AVXL $4.00
  • 52 Week High
  • GETY $4.49
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • GETY 49.69
  • AVXL 75.85
  • Support Level
  • GETY $1.60
  • AVXL $9.08
  • Resistance Level
  • GETY $1.78
  • AVXL $9.78
  • Average True Range (ATR)
  • GETY 0.09
  • AVXL 0.53
  • MACD
  • GETY -0.00
  • AVXL 0.19
  • Stochastic Oscillator
  • GETY 43.55
  • AVXL 95.03

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: